ID   PDXK_ECOLI              Reviewed;         283 AA.
AC   P40191; P76964;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   15-FEB-2017, entry version 138.
DE   RecName: Full=Pyridoxine/pyridoxal/pyridoxamine kinase {ECO:0000303|PubMed:8764513, ECO:0000303|PubMed:9537380};
DE            Short=PN/PL/PM kinase {ECO:0000303|PubMed:8764513};
DE            EC=2.7.1.35 {ECO:0000269|PubMed:15249053, ECO:0000269|PubMed:9537380};
DE   AltName: Full=B6-vitamer kinase {ECO:0000303|PubMed:8764513};
DE   AltName: Full=Pyridoxal kinase 1 {ECO:0000303|PubMed:15249053};
DE            Short=PL kinase 1 {ECO:0000303|PubMed:15249053};
GN   Name=pdxK; Synonyms=yfeI; OrderedLocusNames=b2418, JW2411;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8764513; DOI=10.1111/j.1574-6968.1996.tb08368.x;
RA   Yang Y., Zhao G., Winkler M.E.;
RT   "Identification of the pdxK gene that encodes pyridoxine (vitamin B6)
RT   kinase in Escherichia coli K-12.";
RL   FEMS Microbiol. Lett. 141:89-95(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9205837; DOI=10.1093/dnares/4.2.91;
RA   Yamamoto Y., Aiba H., Baba T., Hayashi K., Inada T., Isono K.,
RA   Itoh T., Kimura S., Kitagawa M., Makino K., Miki T., Mitsuhashi N.,
RA   Mizobuchi K., Mori H., Nakade S., Nakamura Y., Nashimoto H.,
RA   Oshima T., Oyama S., Saito N., Sampei G., Satoh Y., Sivasundaram S.,
RA   Tagami H., Takahashi H., Takeda J., Takemoto K., Uehara K., Wada C.,
RA   Yamagata S., Horiuchi T.;
RT   "Construction of a contiguous 874-kb sequence of the Escherichia coli-
RT   K12 genome corresponding to 50.0-68.8 min on the linkage map and
RT   analysis of its sequence features.";
RL   DNA Res. 4:91-113(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 250-283.
RX   PubMed=2457575;
RA   de Reuse H., Danchin A.;
RT   "The ptsH, ptsI, and crr genes of the Escherichia coli
RT   phosphoenolpyruvate-dependent phosphotransferase system: a complex
RT   operon with several modes of transcription.";
RL   J. Bacteriol. 170:3827-3837(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 280-283.
RX   PubMed=2960675;
RA   Saffen D.W., Presper K.A., Doering T.L., Roseman S.;
RT   "Sugar transport by the bacterial phosphotransferase system. Molecular
RT   cloning and structural analysis of the Escherichia coli ptsH, ptsI,
RT   and crr genes.";
RL   J. Biol. Chem. 262:16241-16253(1987).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, DISRUPTION PHENOTYPE, AND PATHWAY.
RC   STRAIN=K12;
RX   PubMed=9537380;
RA   Yang Y., Tsui H.C., Man T.K., Winkler M.E.;
RT   "Identification and function of the pdxY gene, which encodes a novel
RT   pyridoxal kinase involved in the salvage pathway of pyridoxal 5'-
RT   phosphate biosynthesis in Escherichia coli K-12.";
RL   J. Bacteriol. 180:1814-1821(1998).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   COFACTOR.
RX   PubMed=15249053; DOI=10.1016/j.pep.2004.04.021;
RA   di Salvo M.L., Hunt S., Schirch V.;
RT   "Expression, purification, and kinetic constants for human and
RT   Escherichia coli pyridoxal kinases.";
RL   Protein Expr. Purif. 36:300-306(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF APOENZYME AND IN COMPLEXES
RP   WITH MG-ATP AND PYRIDOXAL, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME
RP   REGULATION, AND SUBUNIT.
RX   PubMed=16740960; DOI=10.1128/JB.00122-06;
RA   Safo M.K., Musayev F.N., di Salvo M.L., Hunt S., Claude J.B.,
RA   Schirch V.;
RT   "Crystal structure of pyridoxal kinase from the Escherichia coli pdxK
RT   gene: implications for the classification of pyridoxal kinases.";
RL   J. Bacteriol. 188:4542-4552(2006).
CC   -!- FUNCTION: B6-vitamer kinase involved in the salvage pathway of
CC       pyridoxal 5'-phosphate (PLP). Catalyzes the phosphorylation of
CC       pyridoxine (PN), pyridoxal (PL), and pyridoxamine (PM), forming
CC       their respective 5'-phosphorylated esters, i.e. PNP, PLP and PMP.
CC       {ECO:0000269|PubMed:15249053, ECO:0000269|PubMed:9537380}.
CC   -!- CATALYTIC ACTIVITY: ATP + pyridoxal = ADP + pyridoxal 5'-
CC       phosphate. {ECO:0000269|PubMed:15249053,
CC       ECO:0000269|PubMed:9537380}.
CC   -!- CATALYTIC ACTIVITY: ATP + pyridoxine = ADP + pyridoxine 5'-
CC       phosphate. {ECO:0000269|PubMed:15249053,
CC       ECO:0000269|PubMed:9537380}.
CC   -!- CATALYTIC ACTIVITY: ATP + pyridoxamine = ADP + pyridoxamine 5'-
CC       phosphate. {ECO:0000269|PubMed:15249053}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:15249053};
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15249053};
CC       Note=Can use both zinc and magnesium that is complexed with ATP.
CC       However, magnesium seems to be the preferred metal used under
CC       physiological conditions. {ECO:0000269|PubMed:15249053};
CC   -!- ENZYME REGULATION: Is activated by the monovalent cation
CC       potassium. {ECO:0000269|PubMed:16740960}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=100 uM for pyridoxal (in the presence of MgATP, at pH 7.3 and
CC         37 degrees Celsius) {ECO:0000269|PubMed:15249053};
CC         KM=50 uM for pyridoxal (in the presence of MgATP, at pH 7.3 and
CC         37 degrees Celsius) {ECO:0000269|PubMed:16740960};
CC         KM=190 uM for pyridoxal (in the presence of ZnATP, at pH 7.3 and
CC         37 degrees Celsius) {ECO:0000269|PubMed:15249053};
CC         KM=25 uM for pyridoxine (in the presence of MgATP, at pH 7.3 and
CC         37 degrees Celsius) {ECO:0000269|PubMed:15249053};
CC         KM=30 uM for pyridoxamine (in the presence of MgATP, at pH 7.3
CC         and 37 degrees Celsius) {ECO:0000269|PubMed:15249053};
CC         KM=10 uM for pyridoxamine (in the presence of ZnATP, at pH 7.3
CC         and 37 degrees Celsius) {ECO:0000269|PubMed:15249053};
CC         KM=600 uM for MgATP (at pH 7.3 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:15249053};
CC         KM=450 uM for MgATP (at pH 7.3 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:16740960};
CC         KM=2100 uM for MgATP (at pH 6.1 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:15249053};
CC         KM=70 uM for ZnATP (in the presence of pyridoxal, at pH 7.3 and
CC         37 degrees Celsius) {ECO:0000269|PubMed:15249053};
CC         KM=45 uM for ZnATP (in the presence of pyridoxamine, at pH 7.3
CC         and 37 degrees Celsius) {ECO:0000269|PubMed:15249053};
CC         Note=kcat is 140 min(-1) for the phosphorylation of PL with
CC         MgATP. kcat is 120 min(-1) for the phosphorylation of PL with
CC         ZnATP. kcat is 20 min(-1) for the phosphorylation of PN with
CC         MgATP. kcat is 40 min(-1) for the phosphorylation of PM with
CC         MgATP. kcat is 25 min(-1) for the phosphorylation of PM with
CC         ZnATP (at pH 7.3 and 37 degrees Celsius) (PubMed:15249053). kcat
CC         is 250 min(-1) for the phosphorylation of PL with MgATP (at pH
CC         7.3 and 37 degrees Celsius) (PubMed:16740960).
CC         {ECO:0000269|PubMed:15249053, ECO:0000269|PubMed:16740960};
CC   -!- PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage;
CC       pyridoxal 5'-phosphate from pyridoxal: step 1/1.
CC       {ECO:0000269|PubMed:9537380}.
CC   -!- PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage;
CC       pyridoxine 5'-phosphate from pyridoxine: step 1/1.
CC       {ECO:0000269|PubMed:9537380}.
CC   -!- PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage;
CC       pyridoxamine 5'-phosphate from pyridoxamine: step 1/1.
CC       {ECO:0000305|PubMed:15249053}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16740960}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene lack pyridoxine
CC       kinase activity but still contain pyridoxal kinase activity
CC       (PubMed:8764513). Cells lacking this gene and cells lacking both
CC       pdxY and pdxK are not auxotrophs, meaning that the de novo pathway
CC       of PLP biosynthesis is functional. For PLP salvage, the pdxY
CC       single mutant can use both pyridoxine and pyridoxal, the pdxK
CC       single mutant can use pyridoxal but not pyridoxine, and the double
CC       mutant can no longer use both compounds (PubMed:9537380).
CC       {ECO:0000269|PubMed:8764513, ECO:0000269|PubMed:9537380}.
CC   -!- SIMILARITY: Belongs to the pyridoxine kinase family. PdxK
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U53700; AAC44166.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75471.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA16292.1; -; Genomic_DNA.
DR   EMBL; M21994; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; J02796; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A65016; A65016.
DR   RefSeq; NP_416913.1; NC_000913.3.
DR   RefSeq; WP_000096674.1; NZ_LN832404.1.
DR   PDB; 2DDM; X-ray; 2.10 A; A/B=1-283.
DR   PDB; 2DDO; X-ray; 2.60 A; A/B=1-283.
DR   PDB; 2DDW; X-ray; 3.20 A; A/B=1-283.
DR   PDBsum; 2DDM; -.
DR   PDBsum; 2DDO; -.
DR   PDBsum; 2DDW; -.
DR   ProteinModelPortal; P40191; -.
DR   SMR; P40191; -.
DR   BioGrid; 4260568; 17.
DR   IntAct; P40191; 6.
DR   STRING; 511145.b2418; -.
DR   PaxDb; P40191; -.
DR   PRIDE; P40191; -.
DR   EnsemblBacteria; AAC75471; AAC75471; b2418.
DR   EnsemblBacteria; BAA16292; BAA16292; BAA16292.
DR   GeneID; 946881; -.
DR   KEGG; ecj:JW2411; -.
DR   KEGG; eco:b2418; -.
DR   PATRIC; 32120219; VBIEscCol129921_2512.
DR   EchoBASE; EB2519; -.
DR   EcoGene; EG12642; pdxK.
DR   eggNOG; ENOG4107XGF; Bacteria.
DR   eggNOG; COG2240; LUCA.
DR   HOGENOM; HOG000258173; -.
DR   InParanoid; P40191; -.
DR   KO; K00868; -.
DR   OMA; WVAITSA; -.
DR   PhylomeDB; P40191; -.
DR   BioCyc; EcoCyc:PDXK-MONOMER; -.
DR   BioCyc; MetaCyc:PDXK-MONOMER; -.
DR   BRENDA; 2.7.1.35; 2026.
DR   UniPathway; UPA01068; UER00298.
DR   UniPathway; UPA01068; UER00299.
DR   UniPathway; UPA01068; UER00300.
DR   EvolutionaryTrace; P40191; -.
DR   PRO; PR:P40191; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0005524; F:ATP binding; IDA:EcoCyc.
DR   GO; GO:0008902; F:hydroxymethylpyrimidine kinase activity; IMP:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IDA:EcoCyc.
DR   GO; GO:0008478; F:pyridoxal kinase activity; IDA:EcoCyc.
DR   GO; GO:0016310; P:phosphorylation; IDA:EcoCyc.
DR   GO; GO:0009443; P:pyridoxal 5'-phosphate salvage; IDA:EcoCyc.
DR   GO; GO:0008615; P:pyridoxine biosynthetic process; IMP:EcoCyc.
DR   CDD; cd01173; pyridoxal_pyridoxamine_kinase; 1.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   HAMAP; MF_01638; PdxK; 1.
DR   InterPro; IPR023479; PdxK.
DR   InterPro; IPR013749; PM/HMP-P_kinase-1.
DR   InterPro; IPR004625; PyrdxlKinase.
DR   InterPro; IPR029056; Ribokinase-like.
DR   PANTHER; PTHR10534; PTHR10534; 1.
DR   Pfam; PF08543; Phos_pyr_kin; 1.
DR   SUPFAM; SSF53613; SSF53613; 1.
DR   TIGRFAMs; TIGR00687; pyridox_kin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Reference proteome; Transferase;
KW   Zinc.
FT   CHAIN         1    283       Pyridoxine/pyridoxal/pyridoxamine kinase.
FT                                /FTId=PRO_0000213342.
FT   NP_BIND     221    224       ATP. {ECO:0000244|PDB:2DDO,
FT                                ECO:0000269|PubMed:16740960}.
FT   METAL       136    136       Magnesium. {ECO:0000305|PubMed:16740960}.
FT   METAL       162    162       Magnesium. {ECO:0000269|PubMed:16740960}.
FT   BINDING      23     23       Substrate. {ECO:0000244|PDB:2DDW,
FT                                ECO:0000269|PubMed:16740960}.
FT   BINDING      59     59       Substrate. {ECO:0000244|PDB:2DDW,
FT                                ECO:0000269|PubMed:16740960}.
FT   BINDING     125    125       ATP. {ECO:0000244|PDB:2DDO,
FT                                ECO:0000269|PubMed:16740960}.
FT   BINDING     157    157       ATP; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:2DDO,
FT                                ECO:0000269|PubMed:16740960}.
FT   BINDING     162    162       ATP. {ECO:0000244|PDB:2DDO,
FT                                ECO:0000269|PubMed:16740960}.
FT   BINDING     195    195       ATP. {ECO:0000244|PDB:2DDO,
FT                                ECO:0000269|PubMed:16740960}.
FT   BINDING     231    231       ATP. {ECO:0000244|PDB:2DDO,
FT                                ECO:0000269|PubMed:16740960}.
FT   BINDING     233    233       Substrate. {ECO:0000244|PDB:2DDW,
FT                                ECO:0000269|PubMed:16740960}.
FT   STRAND       17     30       {ECO:0000244|PDB:2DDM}.
FT   HELIX        32     41       {ECO:0000244|PDB:2DDM}.
FT   STRAND       46     56       {ECO:0000244|PDB:2DDM}.
FT   STRAND       65     67       {ECO:0000244|PDB:2DDM}.
FT   HELIX        70     82       {ECO:0000244|PDB:2DDM}.
FT   STRAND       91     94       {ECO:0000244|PDB:2DDM}.
FT   HELIX       100    114       {ECO:0000244|PDB:2DDM}.
FT   STRAND      121    124       {ECO:0000244|PDB:2DDM}.
FT   TURN        131    133       {ECO:0000244|PDB:2DDM}.
FT   HELIX       141    147       {ECO:0000244|PDB:2DDM}.
FT   HELIX       150    152       {ECO:0000244|PDB:2DDM}.
FT   STRAND      154    156       {ECO:0000244|PDB:2DDM}.
FT   HELIX       160    167       {ECO:0000244|PDB:2DDM}.
FT   HELIX       174    184       {ECO:0000244|PDB:2DDM}.
FT   STRAND      191    198       {ECO:0000244|PDB:2DDM}.
FT   STRAND      205    212       {ECO:0000244|PDB:2DDM}.
FT   STRAND      215    222       {ECO:0000244|PDB:2DDM}.
FT   HELIX       231    244       {ECO:0000244|PDB:2DDM}.
FT   HELIX       249    269       {ECO:0000244|PDB:2DDM}.
SQ   SEQUENCE   283 AA;  30847 MW;  8DFEDADD2F589EA0 CRC64;
     MSSLLLFNDK SRALQADIVA VQSQVVYGSV GNSIAVPAIK QNGLNVFAVP TVLLSNTPHY
     DTFYGGAIPD EWFSGYLRAL QERDALRQLR AVTTGYMGTA SQIKILAEWL TALRKDHPDL
     LIMVDPVIGD IDSGIYVKPD LPEAYRQYLL PLAQGITPNI FELEILTGKN CRDLDSAIAA
     AKSLLSDTLK WVVVTSASGN EENQEMQVVV VTADSVNVIS HSRVKTDLKG TGDLFCAQLI
     SGLLKGKALT DAVHRAGLRV LEVMRYTQQH ESDELILPPL AEA
//
